Life sciences & healthcare
Click here to find out more
Will the UK government's COVID-19 dosing regime gamble pay off?
11 January 2021
Briefing
by Alison Dennis and Justyna Ostrowska
Coronavirus
Click here to find out more
Next Normal Legal ‒ The Legal Situation in Germany after Covid-19
8 December 2020
Technology, media & communications
Click here to find out more
Life sciences and healthcare predictions 2021: more politics
4 December 2020
Briefing
by Alison Dennis and Justyna Ostrowska
Data protection & cyber
Click here to find out more
Global Data Hub - Health data
27 November 2020
Quick read
by multiple authors
Life sciences & healthcare
Click here to find out more
Russian coronavirus vaccine – approval process in Hungary and the EU
Available in Hungarian
24 November 2020
Briefing
Patents & innovation
Click here to find out more
Pharmaceutical patent law in times of crisis: A comparative study – Part 2
23 November 2020
Quick read
by multiple authors
Patents & innovation
Click here to find out more
Pharmaceutical patent law in times of crisis: A comparative study – Part 1
9 November 2020
Quick read
by multiple authors
Life sciences & healthcare
Click here to find out more
Return to work: key issues for life sciences
4 August 2020
QUICK READ
by Helen Farr and Adrian Toutoungi
Technology, media & communications
Click here to find out more
Future Fund: update to connected person test following Taylor Wessing (and others) request for changes
9 July 2020
QUICK READ
by multiple authors
Life sciences & healthcare
Click here to find out more
Impact of COVID-19 on venture-backed biotech companies – Part 2: Investment and cash flow
23 June 2020
IN-DEPTH ANALYSIS
by Adrian Toutoungi and Josef Fuss
Life sciences & healthcare
Click here to find out more
Impact of COVID-19 on venture-backed biotech companies – Part 1: Operational issues
22 June 2020
IN-DEPTH ANALYSIS
by Adrian Toutoungi and Josef Fuss